XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total
Beginning balance at Dec. 31, 2022 $ 141 $ 94,726   $ 146,630 $ (28,697)   $ 212,800
Beginning balance (in shares) at Dec. 31, 2022 14,043,801            
Net Income (Loss)       656     656
Other comprehensive income (loss)         11,727   11,727
Cash dividends attributable to changes in common shares       (3,108)     (3,108)
Exercise of stock options   320         320
Exercise of stock options (in shares) 27,375            
Restricted stock vesting (in shares) 9,037            
Share-based compensation   464         464
Ending balance at Sep. 30, 2023 $ 141 95,510 $ (2,292) 141,886 (16,970) $ (2,292) 220,567
Ending balance (in shares) at Sep. 30, 2023 14,080,213            
Beginning balance at Jun. 30, 2023 $ 141 95,380   152,024 (28,575)   218,970
Beginning balance (in shares) at Jun. 30, 2023 14,079,847            
Net Income (Loss)       (10,137)     (10,137)
Other comprehensive income (loss)         11,605   11,605
Cash dividends attributable to changes in common shares       (1)     (1)
Restricted stock vesting (in shares) 366            
Share-based compensation   130         130
Ending balance at Sep. 30, 2023 $ 141 95,510 $ (2,292) 141,886 (16,970) $ (2,292) 220,567
Ending balance (in shares) at Sep. 30, 2023 14,080,213            
Beginning balance at Dec. 31, 2023 $ 141 95,636   146,388 (12,251)   229,914
Beginning balance (in shares) at Dec. 31, 2023 14,101,215            
Net Income (Loss)       12,344     12,344
Other comprehensive income (loss)         3,036   3,036
Repurchase of common stock   (49)         (49)
Repurchase of common stock (in shares) (3,003)            
Cash dividends attributable to changes in common shares       (3,558)     (3,558)
Exercise of stock options, net of shares surrendered $ 1 1,036         1,037
Exercise of stock options, net of shares surrendered (in shares) 92,038            
Restricted stock vesting   (3)         (3)
Restricted stock vesting (in shares) 2,674            
Share-based compensation   397         397
Ending balance at Sep. 30, 2024 $ 142 97,017   155,174 (9,215)   243,118
Ending balance (in shares) at Sep. 30, 2024 14,192,924            
Beginning balance at Jun. 30, 2024 $ 142 96,817   150,942 (12,555)   235,346
Beginning balance (in shares) at Jun. 30, 2024 14,183,600            
Net Income (Loss)       4,235     4,235
Other comprehensive income (loss)         3,340   3,340
Cash dividends attributable to changes in common shares       (3)     (3)
Exercise of stock options   68         68
Exercise of stock options (in shares) 9,324            
Share-based compensation   132         132
Ending balance at Sep. 30, 2024 $ 142 $ 97,017   $ 155,174 $ (9,215)   $ 243,118
Ending balance (in shares) at Sep. 30, 2024 14,192,924